GL
IDXX icon

Graypoint LLC’s Idexx Laboratories IDXX Stock Holding History

Graypoint LLC’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$603K Buy
+1,124
New +$537K 0.03% 296
2025
Q1 		– Sell
-528
Closed -$218K – 518
2024
Q4 		$218K Sell
528
-82
-13% -$36K 0.01% 487
2024
Q3 		$308K Buy
610
+88
+17% +$42.8K 0.02% 392
2024
Q2 		$254K Buy
522
+36
+7% +$18.1K 0.02% 413
2024
Q1 		$262K Sell
486
-10
-2% -$5.46K 0.02% 399
2023
Q4 		$275K Buy
+496
New +$233K 0.02% 363

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Graypoint LLC's IDXX Position: Q2 2025 in Review

Graypoint LLC opened a new position in Idexx Laboratories (IDXX) in Q2 2025: 1,124 shares worth $603K. The stake represents 0.03% of the portfolio and ranks #296 among its holdings. This is a return to the name: Graypoint LLC previously reported a position in IDXX as recently as Q4 2024.

Graypoint LLC first reported a position in IDXX in Q4 2023 and has held it in 6 quarters since. 1,234 funds tracked by Wall St. Rank hold IDXX as of Q2 2025.

  • Graypoint LLC held 1,124 shares of Idexx Laboratories worth $603K as of Q2 2025.
  • Idexx Laboratories was a new Graypoint LLC position in Q2 2025.
  • Idexx Laboratories made up 0.03% of Graypoint LLC's portfolio in Q2 2025, its #296 holding.
  • Graypoint LLC first reported a position in Idexx Laboratories in Q4 2023 and has held it in 6 quarters since.
  • 1,234 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2025.

Based on Graypoint LLC's 13F filing for Q2 2025, filed 15 Jul 2025.